nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—PTGS1—Etoposide—sarcoma	0.111	0.163	CbGbCtD
Nateglinide—CYP3A7—Vincristine—sarcoma	0.097	0.142	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.097	0.142	CbGbCtD
Nateglinide—CYP3A4—Thiotepa—sarcoma	0.0959	0.141	CbGbCtD
Nateglinide—CYP3A5—Vincristine—sarcoma	0.0727	0.107	CbGbCtD
Nateglinide—CYP3A5—Etoposide—sarcoma	0.0666	0.0978	CbGbCtD
Nateglinide—CYP3A4—Mitoxantrone—sarcoma	0.0412	0.0605	CbGbCtD
Nateglinide—CYP3A4—Vincristine—sarcoma	0.0284	0.0416	CbGbCtD
Nateglinide—CYP2D6—Doxorubicin—sarcoma	0.0279	0.0409	CbGbCtD
Nateglinide—CYP3A4—Etoposide—sarcoma	0.026	0.0381	CbGbCtD
Nateglinide—CYP3A4—Doxorubicin—sarcoma	0.0177	0.026	CbGbCtD
Nateglinide—PPARG—dermis—sarcoma	0.0164	0.0796	CbGeAlD
Nateglinide—PPARG—periosteum—sarcoma	0.0135	0.0659	CbGeAlD
Nateglinide—PPARG—leg—sarcoma	0.0108	0.0526	CbGeAlD
Nateglinide—PPARG—forelimb—sarcoma	0.0107	0.0522	CbGeAlD
Nateglinide—PPARG—hindlimb—sarcoma	0.00964	0.0469	CbGeAlD
Nateglinide—PPARG—Teniposide—Etoposide—sarcoma	0.00878	1	CbGdCrCtD
Nateglinide—PPARG—appendage—sarcoma	0.00827	0.0403	CbGeAlD
Nateglinide—KCNJ11—mammary gland—sarcoma	0.00572	0.0279	CbGeAlD
Nateglinide—ABCC8—mammary gland—sarcoma	0.00527	0.0257	CbGeAlD
Nateglinide—PPARG—endothelium—sarcoma	0.00499	0.0243	CbGeAlD
Nateglinide—PPARG—mammary gland—sarcoma	0.00402	0.0196	CbGeAlD
Nateglinide—ALB—mammary gland—sarcoma	0.00378	0.0184	CbGeAlD
Nateglinide—KCNJ11—hematopoietic system—sarcoma	0.00349	0.017	CbGeAlD
Nateglinide—ABCC8—seminal vesicle—sarcoma	0.00338	0.0165	CbGeAlD
Nateglinide—SLC15A2—mammary gland—sarcoma	0.00315	0.0153	CbGeAlD
Nateglinide—SLC16A1—hematopoietic system—sarcoma	0.00292	0.0142	CbGeAlD
Nateglinide—ABCC8—smooth muscle tissue—sarcoma	0.00283	0.0138	CbGeAlD
Nateglinide—PPARG—embryo—sarcoma	0.00275	0.0134	CbGeAlD
Nateglinide—PTGS1—endothelium—sarcoma	0.00267	0.013	CbGeAlD
Nateglinide—ORM1—hematopoietic system—sarcoma	0.00262	0.0128	CbGeAlD
Nateglinide—UGT1A9—liver—sarcoma	0.00258	0.0126	CbGeAlD
Nateglinide—KCNJ11—lymphoid tissue—sarcoma	0.00246	0.012	CbGeAlD
Nateglinide—PPARG—hematopoietic system—sarcoma	0.00245	0.0119	CbGeAlD
Nateglinide—Hepatic enzyme increased—Mitoxantrone—sarcoma	0.00244	0.0234	CcSEcCtD
Nateglinide—PPARG—connective tissue—sarcoma	0.00236	0.0115	CbGeAlD
Nateglinide—CYP2C9—mammary gland—sarcoma	0.00236	0.0115	CbGeAlD
Nateglinide—KCNJ11—tendon—sarcoma	0.00231	0.0112	CbGeAlD
Nateglinide—ABCC4—hematopoietic system—sarcoma	0.00223	0.0108	CbGeAlD
Nateglinide—SLC16A1—cardiac atrium—sarcoma	0.00222	0.0108	CbGeAlD
Nateglinide—SLC16A1—uterus—sarcoma	0.00221	0.0107	CbGeAlD
Nateglinide—PPARG—smooth muscle tissue—sarcoma	0.00216	0.0105	CbGeAlD
Nateglinide—CYP3A7—liver—sarcoma	0.00215	0.0105	CbGeAlD
Nateglinide—Urine output increased—Vincristine—sarcoma	0.00215	0.0206	CcSEcCtD
Nateglinide—PPARG—skin of body—sarcoma	0.00213	0.0104	CbGeAlD
Nateglinide—SLC15A2—seminal vesicle—sarcoma	0.00202	0.00983	CbGeAlD
Nateglinide—Polyuria—Vincristine—sarcoma	0.00196	0.0188	CcSEcCtD
Nateglinide—SLC16A1—tendon—sarcoma	0.00193	0.00942	CbGeAlD
Nateglinide—PPARG—uterus—sarcoma	0.00185	0.00902	CbGeAlD
Nateglinide—CYP3A7-CYP3A51P—liver—sarcoma	0.00183	0.00889	CbGeAlD
Nateglinide—ABCC8—testis—sarcoma	0.00176	0.00857	CbGeAlD
Nateglinide—PPARG—lymphoid tissue—sarcoma	0.00173	0.0084	CbGeAlD
Nateglinide—ABCC4—uterus—sarcoma	0.00168	0.00819	CbGeAlD
Nateglinide—ORM1—bone marrow—sarcoma	0.00168	0.00819	CbGeAlD
Nateglinide—PPARG—tendon—sarcoma	0.00162	0.0079	CbGeAlD
Nateglinide—SLC16A1—testis—sarcoma	0.0016	0.0078	CbGeAlD
Nateglinide—SLC15A1—liver—sarcoma	0.00159	0.00775	CbGeAlD
Nateglinide—PPARG—bone marrow—sarcoma	0.00157	0.00765	CbGeAlD
Nateglinide—SLC16A1—liver—sarcoma	0.00151	0.00737	CbGeAlD
Nateglinide—ABCC4—tendon—sarcoma	0.00147	0.00717	CbGeAlD
Nateglinide—Jaundice—Thiotepa—sarcoma	0.00146	0.014	CcSEcCtD
Nateglinide—CYP3A5—hematopoietic system—sarcoma	0.00146	0.0071	CbGeAlD
Nateglinide—CYP2C9—hematopoietic system—sarcoma	0.00144	0.00699	CbGeAlD
Nateglinide—ABCC4—bone marrow—sarcoma	0.00143	0.00695	CbGeAlD
Nateglinide—Hepatobiliary disease—Thiotepa—sarcoma	0.00142	0.0136	CcSEcCtD
Nateglinide—Sweating increased—Mitoxantrone—sarcoma	0.00141	0.0135	CcSEcCtD
Nateglinide—KCNJ11—lymph node—sarcoma	0.00139	0.00674	CbGeAlD
Nateglinide—PTGS1—seminal vesicle—sarcoma	0.00138	0.00671	CbGeAlD
Nateglinide—ORM1—liver—sarcoma	0.00136	0.00662	CbGeAlD
Nateglinide—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.00135	0.0129	CcSEcCtD
Nateglinide—PPARG—testis—sarcoma	0.00134	0.00654	CbGeAlD
Nateglinide—PTGS1—hematopoietic system—sarcoma	0.00131	0.00638	CbGeAlD
Nateglinide—Neuropathy peripheral—Vincristine—sarcoma	0.0013	0.0125	CcSEcCtD
Nateglinide—Sweating—Vincristine—sarcoma	0.00127	0.0122	CcSEcCtD
Nateglinide—PPARG—liver—sarcoma	0.00127	0.00618	CbGeAlD
Nateglinide—PTGS1—connective tissue—sarcoma	0.00126	0.00614	CbGeAlD
Nateglinide—Erythema multiforme—Dactinomycin—sarcoma	0.00126	0.0121	CcSEcCtD
Nateglinide—Jaundice—Mitoxantrone—sarcoma	0.00126	0.0121	CcSEcCtD
Nateglinide—ALB—testis—sarcoma	0.00126	0.00614	CbGeAlD
Nateglinide—Sweating—Mitoxantrone—sarcoma	0.00124	0.0119	CcSEcCtD
Nateglinide—ABCC4—testis—sarcoma	0.00122	0.00594	CbGeAlD
Nateglinide—Immune system disorder—Thiotepa—sarcoma	0.00121	0.0116	CcSEcCtD
Nateglinide—ALB—liver—sarcoma	0.00119	0.0058	CbGeAlD
Nateglinide—Arthropathy—Epirubicin—sarcoma	0.00119	0.0114	CcSEcCtD
Nateglinide—Sweating increased—Etoposide—sarcoma	0.00118	0.0113	CcSEcCtD
Nateglinide—Malnutrition—Thiotepa—sarcoma	0.00117	0.0112	CcSEcCtD
Nateglinide—SLC16A1—lymph node—sarcoma	0.00116	0.00565	CbGeAlD
Nateglinide—PTGS1—smooth muscle tissue—sarcoma	0.00115	0.00562	CbGeAlD
Nateglinide—ABCC4—liver—sarcoma	0.00115	0.00562	CbGeAlD
Nateglinide—PTGS1—skin of body—sarcoma	0.00114	0.00555	CbGeAlD
Nateglinide—Back pain—Thiotepa—sarcoma	0.00113	0.0108	CcSEcCtD
Nateglinide—Arthropathy—Doxorubicin—sarcoma	0.0011	0.0105	CcSEcCtD
Nateglinide—CYP3A4—hematopoietic system—sarcoma	0.00109	0.00533	CbGeAlD
Nateglinide—CYP2D6—hematopoietic system—sarcoma	0.00108	0.00525	CbGeAlD
Nateglinide—Neuropathy peripheral—Etoposide—sarcoma	0.00105	0.0101	CcSEcCtD
Nateglinide—SLC15A2—testis—sarcoma	0.00105	0.00512	CbGeAlD
Nateglinide—Jaundice—Etoposide—sarcoma	0.00105	0.01	CcSEcCtD
Nateglinide—ORM1—lymph node—sarcoma	0.00104	0.00507	CbGeAlD
Nateglinide—Cough—Thiotepa—sarcoma	0.00102	0.00979	CcSEcCtD
Nateglinide—Hepatobiliary disease—Etoposide—sarcoma	0.00102	0.00975	CcSEcCtD
Nateglinide—Back pain—Vincristine—sarcoma	0.001	0.00962	CcSEcCtD
Nateglinide—PTGS1—cardiac atrium—sarcoma	0.000995	0.00485	CbGeAlD
Nateglinide—PTGS1—uterus—sarcoma	0.00099	0.00482	CbGeAlD
Nateglinide—Back pain—Mitoxantrone—sarcoma	0.000978	0.00937	CcSEcCtD
Nateglinide—PPARG—lymph node—sarcoma	0.000974	0.00474	CbGeAlD
Nateglinide—ALB—lymph node—sarcoma	0.000914	0.00445	CbGeAlD
Nateglinide—Erythema multiforme—Etoposide—sarcoma	0.000913	0.00875	CcSEcCtD
Nateglinide—ABCC4—lymph node—sarcoma	0.000884	0.00431	CbGeAlD
Nateglinide—Cough—Mitoxantrone—sarcoma	0.000882	0.00845	CcSEcCtD
Nateglinide—Immune system disorder—Etoposide—sarcoma	0.000873	0.00836	CcSEcCtD
Nateglinide—PTGS1—tendon—sarcoma	0.000867	0.00422	CbGeAlD
Nateglinide—Dyspepsia—Thiotepa—sarcoma	0.000841	0.00806	CcSEcCtD
Nateglinide—Increased appetite—Epirubicin—sarcoma	0.000833	0.00798	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Thiotepa—sarcoma	0.000825	0.0079	CcSEcCtD
Nateglinide—Fatigue—Thiotepa—sarcoma	0.000824	0.00789	CcSEcCtD
Nateglinide—Hyperhidrosis—Vincristine—sarcoma	0.000819	0.00785	CcSEcCtD
Nateglinide—Fatigue—Dactinomycin—sarcoma	0.000818	0.00783	CcSEcCtD
Nateglinide—Back pain—Etoposide—sarcoma	0.000813	0.00779	CcSEcCtD
Nateglinide—Hypoglycaemia—Epirubicin—sarcoma	0.000802	0.00768	CcSEcCtD
Nateglinide—Hyperhidrosis—Mitoxantrone—sarcoma	0.000798	0.00764	CcSEcCtD
Nateglinide—Osteoarthritis—Epirubicin—sarcoma	0.000783	0.0075	CcSEcCtD
Nateglinide—Gastrointestinal pain—Thiotepa—sarcoma	0.000781	0.00749	CcSEcCtD
Nateglinide—Gastrointestinal pain—Dactinomycin—sarcoma	0.000775	0.00743	CcSEcCtD
Nateglinide—Increased appetite—Doxorubicin—sarcoma	0.000771	0.00739	CcSEcCtD
Nateglinide—SLC15A2—lymph node—sarcoma	0.000763	0.00371	CbGeAlD
Nateglinide—Urticaria—Thiotepa—sarcoma	0.000759	0.00727	CcSEcCtD
Nateglinide—CYP3A5—liver—sarcoma	0.000756	0.00368	CbGeAlD
Nateglinide—Abdominal pain—Thiotepa—sarcoma	0.000755	0.00724	CcSEcCtD
Nateglinide—Abdominal pain—Dactinomycin—sarcoma	0.00075	0.00718	CcSEcCtD
Nateglinide—CYP2C9—liver—sarcoma	0.000744	0.00362	CbGeAlD
Nateglinide—Hypoglycaemia—Doxorubicin—sarcoma	0.000742	0.00711	CcSEcCtD
Nateglinide—Cough—Etoposide—sarcoma	0.000734	0.00703	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Vincristine—sarcoma	0.000731	0.00701	CcSEcCtD
Nateglinide—Fatigue—Vincristine—sarcoma	0.00073	0.007	CcSEcCtD
Nateglinide—Dyspepsia—Mitoxantrone—sarcoma	0.000726	0.00696	CcSEcCtD
Nateglinide—Osteoarthritis—Doxorubicin—sarcoma	0.000724	0.00694	CcSEcCtD
Nateglinide—PTGS1—testis—sarcoma	0.000718	0.0035	CbGeAlD
Nateglinide—Fatigue—Mitoxantrone—sarcoma	0.000711	0.00682	CcSEcCtD
Nateglinide—Hypersensitivity—Thiotepa—sarcoma	0.000704	0.00674	CcSEcCtD
Nateglinide—Hypersensitivity—Dactinomycin—sarcoma	0.000699	0.00669	CcSEcCtD
Nateglinide—Gastrointestinal pain—Vincristine—sarcoma	0.000693	0.00664	CcSEcCtD
Nateglinide—Asthenia—Thiotepa—sarcoma	0.000685	0.00657	CcSEcCtD
Nateglinide—Asthenia—Dactinomycin—sarcoma	0.00068	0.00652	CcSEcCtD
Nateglinide—Influenza—Epirubicin—sarcoma	0.000676	0.00648	CcSEcCtD
Nateglinide—Pruritus—Thiotepa—sarcoma	0.000676	0.00648	CcSEcCtD
Nateglinide—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000675	0.00646	CcSEcCtD
Nateglinide—Abdominal pain—Vincristine—sarcoma	0.00067	0.00642	CcSEcCtD
Nateglinide—Hyperhidrosis—Etoposide—sarcoma	0.000663	0.00636	CcSEcCtD
Nateglinide—Urticaria—Mitoxantrone—sarcoma	0.000655	0.00628	CcSEcCtD
Nateglinide—Diarrhoea—Thiotepa—sarcoma	0.000654	0.00626	CcSEcCtD
Nateglinide—Abdominal pain—Mitoxantrone—sarcoma	0.000652	0.00625	CcSEcCtD
Nateglinide—Bronchitis—Epirubicin—sarcoma	0.000651	0.00623	CcSEcCtD
Nateglinide—Diarrhoea—Dactinomycin—sarcoma	0.000649	0.00622	CcSEcCtD
Nateglinide—Dizziness—Thiotepa—sarcoma	0.000632	0.00605	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Epirubicin—sarcoma	0.000629	0.00602	CcSEcCtD
Nateglinide—Influenza—Doxorubicin—sarcoma	0.000626	0.006	CcSEcCtD
Nateglinide—Hypersensitivity—Vincristine—sarcoma	0.000624	0.00598	CcSEcCtD
Nateglinide—Hypersensitivity—Mitoxantrone—sarcoma	0.000608	0.00582	CcSEcCtD
Nateglinide—Asthenia—Vincristine—sarcoma	0.000608	0.00582	CcSEcCtD
Nateglinide—Vomiting—Thiotepa—sarcoma	0.000607	0.00582	CcSEcCtD
Nateglinide—Vomiting—Dactinomycin—sarcoma	0.000603	0.00578	CcSEcCtD
Nateglinide—Rash—Thiotepa—sarcoma	0.000602	0.00577	CcSEcCtD
Nateglinide—Bronchitis—Doxorubicin—sarcoma	0.000602	0.00577	CcSEcCtD
Nateglinide—Dermatitis—Thiotepa—sarcoma	0.000602	0.00577	CcSEcCtD
Nateglinide—Rash—Dactinomycin—sarcoma	0.000598	0.00573	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Etoposide—sarcoma	0.000592	0.00568	CcSEcCtD
Nateglinide—Asthenia—Mitoxantrone—sarcoma	0.000592	0.00567	CcSEcCtD
Nateglinide—Fatigue—Etoposide—sarcoma	0.000592	0.00567	CcSEcCtD
Nateglinide—Neuropathy peripheral—Epirubicin—sarcoma	0.000591	0.00566	CcSEcCtD
Nateglinide—CYP2D6—testis—sarcoma	0.00059	0.00287	CbGeAlD
Nateglinide—Jaundice—Epirubicin—sarcoma	0.000588	0.00563	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000582	0.00557	CcSEcCtD
Nateglinide—Diarrhoea—Vincristine—sarcoma	0.00058	0.00555	CcSEcCtD
Nateglinide—Sweating—Epirubicin—sarcoma	0.000578	0.00554	CcSEcCtD
Nateglinide—Hepatobiliary disease—Epirubicin—sarcoma	0.00057	0.00547	CcSEcCtD
Nateglinide—Nausea—Thiotepa—sarcoma	0.000568	0.00544	CcSEcCtD
Nateglinide—CYP3A4—liver—sarcoma	0.000567	0.00276	CbGeAlD
Nateglinide—Diarrhoea—Mitoxantrone—sarcoma	0.000565	0.00541	CcSEcCtD
Nateglinide—Nausea—Dactinomycin—sarcoma	0.000563	0.0054	CcSEcCtD
Nateglinide—Gastrointestinal pain—Etoposide—sarcoma	0.000561	0.00538	CcSEcCtD
Nateglinide—Dizziness—Vincristine—sarcoma	0.00056	0.00537	CcSEcCtD
Nateglinide—CYP2D6—liver—sarcoma	0.000558	0.00272	CbGeAlD
Nateglinide—Neuropathy peripheral—Doxorubicin—sarcoma	0.000547	0.00524	CcSEcCtD
Nateglinide—Urticaria—Etoposide—sarcoma	0.000545	0.00522	CcSEcCtD
Nateglinide—Jaundice—Doxorubicin—sarcoma	0.000544	0.00521	CcSEcCtD
Nateglinide—Abdominal pain—Etoposide—sarcoma	0.000543	0.0052	CcSEcCtD
Nateglinide—Vomiting—Vincristine—sarcoma	0.000539	0.00516	CcSEcCtD
Nateglinide—Sweating—Doxorubicin—sarcoma	0.000535	0.00513	CcSEcCtD
Nateglinide—Rash—Vincristine—sarcoma	0.000534	0.00512	CcSEcCtD
Nateglinide—Dermatitis—Vincristine—sarcoma	0.000534	0.00511	CcSEcCtD
Nateglinide—Oedema peripheral—Epirubicin—sarcoma	0.000533	0.00511	CcSEcCtD
Nateglinide—Hepatobiliary disease—Doxorubicin—sarcoma	0.000528	0.00506	CcSEcCtD
Nateglinide—Vomiting—Mitoxantrone—sarcoma	0.000525	0.00503	CcSEcCtD
Nateglinide—PTGS1—lymph node—sarcoma	0.000521	0.00254	CbGeAlD
Nateglinide—Rash—Mitoxantrone—sarcoma	0.00052	0.00498	CcSEcCtD
Nateglinide—Dermatitis—Mitoxantrone—sarcoma	0.00052	0.00498	CcSEcCtD
Nateglinide—Erythema multiforme—Epirubicin—sarcoma	0.000512	0.00491	CcSEcCtD
Nateglinide—Hypersensitivity—Etoposide—sarcoma	0.000506	0.00484	CcSEcCtD
Nateglinide—Nausea—Vincristine—sarcoma	0.000503	0.00482	CcSEcCtD
Nateglinide—Oedema peripheral—Doxorubicin—sarcoma	0.000494	0.00473	CcSEcCtD
Nateglinide—Asthenia—Etoposide—sarcoma	0.000492	0.00472	CcSEcCtD
Nateglinide—Nausea—Mitoxantrone—sarcoma	0.00049	0.0047	CcSEcCtD
Nateglinide—Immune system disorder—Epirubicin—sarcoma	0.000489	0.00469	CcSEcCtD
Nateglinide—Pruritus—Etoposide—sarcoma	0.000486	0.00465	CcSEcCtD
Nateglinide—Erythema multiforme—Doxorubicin—sarcoma	0.000474	0.00454	CcSEcCtD
Nateglinide—Malnutrition—Epirubicin—sarcoma	0.000471	0.00452	CcSEcCtD
Nateglinide—Diarrhoea—Etoposide—sarcoma	0.00047	0.0045	CcSEcCtD
Nateglinide—Back pain—Epirubicin—sarcoma	0.000456	0.00437	CcSEcCtD
Nateglinide—Dizziness—Etoposide—sarcoma	0.000454	0.00435	CcSEcCtD
Nateglinide—Immune system disorder—Doxorubicin—sarcoma	0.000453	0.00434	CcSEcCtD
Nateglinide—Vomiting—Etoposide—sarcoma	0.000436	0.00418	CcSEcCtD
Nateglinide—Malnutrition—Doxorubicin—sarcoma	0.000436	0.00418	CcSEcCtD
Nateglinide—Rash—Etoposide—sarcoma	0.000433	0.00415	CcSEcCtD
Nateglinide—Dermatitis—Etoposide—sarcoma	0.000432	0.00414	CcSEcCtD
Nateglinide—Back pain—Doxorubicin—sarcoma	0.000422	0.00404	CcSEcCtD
Nateglinide—Palpitations—Epirubicin—sarcoma	0.000417	0.00399	CcSEcCtD
Nateglinide—Cough—Epirubicin—sarcoma	0.000411	0.00394	CcSEcCtD
Nateglinide—Nausea—Etoposide—sarcoma	0.000408	0.00391	CcSEcCtD
Nateglinide—Palpitations—Doxorubicin—sarcoma	0.000385	0.00369	CcSEcCtD
Nateglinide—Cough—Doxorubicin—sarcoma	0.000381	0.00365	CcSEcCtD
Nateglinide—Hyperhidrosis—Epirubicin—sarcoma	0.000372	0.00356	CcSEcCtD
Nateglinide—Hyperhidrosis—Doxorubicin—sarcoma	0.000344	0.0033	CcSEcCtD
Nateglinide—Dyspepsia—Epirubicin—sarcoma	0.000339	0.00324	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Epirubicin—sarcoma	0.000332	0.00318	CcSEcCtD
Nateglinide—Fatigue—Epirubicin—sarcoma	0.000332	0.00318	CcSEcCtD
Nateglinide—Gastrointestinal pain—Epirubicin—sarcoma	0.000315	0.00301	CcSEcCtD
Nateglinide—Dyspepsia—Doxorubicin—sarcoma	0.000313	0.003	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000307	0.00294	CcSEcCtD
Nateglinide—Fatigue—Doxorubicin—sarcoma	0.000307	0.00294	CcSEcCtD
Nateglinide—Urticaria—Epirubicin—sarcoma	0.000306	0.00293	CcSEcCtD
Nateglinide—Abdominal pain—Epirubicin—sarcoma	0.000304	0.00291	CcSEcCtD
Nateglinide—Gastrointestinal pain—Doxorubicin—sarcoma	0.000291	0.00279	CcSEcCtD
Nateglinide—Hypersensitivity—Epirubicin—sarcoma	0.000283	0.00272	CcSEcCtD
Nateglinide—Urticaria—Doxorubicin—sarcoma	0.000283	0.00271	CcSEcCtD
Nateglinide—Abdominal pain—Doxorubicin—sarcoma	0.000281	0.0027	CcSEcCtD
Nateglinide—Asthenia—Epirubicin—sarcoma	0.000276	0.00264	CcSEcCtD
Nateglinide—Pruritus—Epirubicin—sarcoma	0.000272	0.00261	CcSEcCtD
Nateglinide—Diarrhoea—Epirubicin—sarcoma	0.000263	0.00252	CcSEcCtD
Nateglinide—Hypersensitivity—Doxorubicin—sarcoma	0.000262	0.00251	CcSEcCtD
Nateglinide—Asthenia—Doxorubicin—sarcoma	0.000255	0.00245	CcSEcCtD
Nateglinide—Dizziness—Epirubicin—sarcoma	0.000254	0.00244	CcSEcCtD
Nateglinide—Pruritus—Doxorubicin—sarcoma	0.000252	0.00241	CcSEcCtD
Nateglinide—Vomiting—Epirubicin—sarcoma	0.000245	0.00234	CcSEcCtD
Nateglinide—Diarrhoea—Doxorubicin—sarcoma	0.000244	0.00233	CcSEcCtD
Nateglinide—Rash—Epirubicin—sarcoma	0.000243	0.00232	CcSEcCtD
Nateglinide—Dermatitis—Epirubicin—sarcoma	0.000242	0.00232	CcSEcCtD
Nateglinide—Dizziness—Doxorubicin—sarcoma	0.000235	0.00226	CcSEcCtD
Nateglinide—Nausea—Epirubicin—sarcoma	0.000229	0.00219	CcSEcCtD
Nateglinide—Vomiting—Doxorubicin—sarcoma	0.000226	0.00217	CcSEcCtD
Nateglinide—Rash—Doxorubicin—sarcoma	0.000224	0.00215	CcSEcCtD
Nateglinide—Dermatitis—Doxorubicin—sarcoma	0.000224	0.00215	CcSEcCtD
Nateglinide—Nausea—Doxorubicin—sarcoma	0.000211	0.00203	CcSEcCtD
